市販の消費者向け健康食品市場：製品別、流通チャネル別-2025～2030年の世界予測

市販の消費者向け健康食品市場は、2023年に6,410億2,000万米ドルと評価され、2024年には6,796億米ドルに達すると予測され、CAGR 6.34％で成長し、2030年には9,859億7,000万米ドルに達すると予測されています。

市販薬（OTC）の範囲と定義には、鎮痛剤、風邪薬、インフルエンザ治療、ビタミン剤、サプリメント、スキンケア製品など、処方箋なしで入手可能な幅広い健康・福祉用品が含まれます。これらの製品は、セルフケアやウェルネスを求める消費者の動向を反映し、即効性のある緩和策や予防策を求める消費者に利便性とアクセシビリティを提供しています。OTC製品の必要性は、健康意識の高まり、高齢化人口の増加、費用対効果の高い医療ソリューションへの嗜好が原動力となっています。OTC製品は、パーソナル医療、ホーム・医療、高齢者ケアなど、さまざまな最終用途セグメントに応用されています。市場洞察によると、OTC消費者向け健康製品の成長は、製品配合における技術的進歩、天然製品やオーガニック製品に対する消費者需要の増加、より簡単なアクセスを可能にするeコマースプラットフォームの拡大といった要因に影響されています。個別化医療製品、製品強化のためのデジタルヘルス技術の活用、新興国の未開拓市場にビジネス機会があります。しかし、厳しい規制環境、製品の潜在的な副作用、多数の市場参入企業による高い競合圧力が市場成長の課題となっています。技術革新の最良のセグメントとしては、個人の健康モニタリングのための統合デジタルソリューションの開発、植物由来・ハーブ配合の研究、環境意識の高い消費者を惹きつけるサステイナブルパッケージングなどが挙げられます。OTC市場の性質はダイナミックで競争が激しく、継続的なイノベーションと消費者の嗜好の変化や規制状況への適応が必要です。企業は、進化する消費者ニーズを理解するための市場調査への投資、先端技術による製品配合の強化、デジタルに敏感な顧客を取り込むための強力なオンラインプラットフォームの構築が推奨されます。新興国市場の流通網を強化し、現地の消費者の嗜好に合わせた製品を開発することも、大きな成長の可能性をもたらします。

市場力学：急速に進化する市販の消費者向け健康食品市場の主要市場洞察を公開

市販の消費者向け健康食品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 市販の消費者向け健康食品の人気の高まり
  • 天然医薬品やサプリメントへの嗜好の高まり
  • 消費者の可処分所得の急増と非必需品への支出の増加
• 市場抑制要因
  • OTC製品の開発コストの高さ
• 市場機会
  • 市販の消費者向け健康食品の開発における継続的な研究開発
  • OTC製品を補完するモバイルアプリや遠隔医療サービスの利用拡大
• 市場課題
  • OTC製品の誤用や副作用の潜在的リスク

ポーターのファイブフォース：市販の消費者向け健康食品市場をナビゲートする戦略ツール

ポーターのファイブフォース：市場情勢の競合情勢を理解する上で重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：市販の消費者向け健康食品市場における外部からの影響の把握

外部マクロ環境要因は、市販の消費者向け健康食品市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：市販の消費者向け健康食品市場における競合情勢の把握

市販の消費者向け健康食品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：市販の消費者向け健康食品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、市販の消費者向け健康食品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：市販の消費者向け健康食品市場における成功への道筋を描く

市販の消費者向け健康食品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 市販の消費者向け健康製品の人気の高まり
    • 天然医薬品やサプリメントへの嗜好の高まり
    • 可処分所得の急増と消費者による非必需品への支出の増加
  • 抑制要因
    • OTC製品の開発コストが高い
  • 機会
    • 市販の消費者向け健康食品の開発における継続的な研究開発
    • OTC製品の提供を補完するモバイルアプリと遠隔医療サービスの利用が増加
  • 課題
    • 市販薬の誤用や副作用の潜在的なリスク
• 市場セグメンテーション分析
  • 製品：健康志向の消費者による栄養補助食品の需要増加
  • 流通チャネル：アクセスの容易さと幅広い製品の入手性により、オンライン流通チャネルの好感度が高まっている
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 市販の消費者向け健康食品市場：製品別

• イントロダクション
• 胃腸薬
• 栄養補助食品
• 経口ケア製品
• スキンケア製品
• 創傷ケア管理製品

第7章 市販の消費者向け健康食品市場：流通チャネル別

• イントロダクション
• 病院薬局
• ハイパーマーケットとスーパーマーケット
• 独立系薬局と小売店
• オンライン販売

第8章 南北アメリカの市販の消費者向け健康食品市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の市販の消費者向け健康食品市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの市販の消費者向け健康食品市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • NEXGEL、北米における消費者向け健康OTC製品の流通と商品化に向けてSTADAとの提携を発表
  • iNova、Mundipharmaの消費者向け医療ブランドを5億4,000万米ドルで買収
  • WellSpring Consumer HealthcareがBayerからOTCスキンケアブランドを買収
• 戦略分析と提言

企業一覧

• 3M Company
• Abbott Laboratories
• Amorepacific, Inc.
• Amway Corporation
• Archer Daniels Midland Company
• B. Braun SE
• Bayer AG
• Beiersdorf AG
• Boehringer Ingelheim GmbH
• Cardiff Sports Nutrition Ltd.
• Cardinal Health, Inc.
• Cipla Limited
• Cliff Bar & Company
• Cosmetic Skin Solutions, LLC
• Dr. Reddy's Laboratories
• DuPont de Nemours, Inc.
• Essity AB
• Estee Lauder Companies Inc.
• FastFill Pack, Inc.
• GKCO Holdings, Inc.
• Glanbia PLC
• GlaxoSmithKline PLC
• Glenmark Pharmaceuticals Ltd.
• InSpec Solutions, LLC
• Integra Lifesciences Corporation
• Johnson & Johnson services, Inc.
• Koninklijke DSM N.V.
• L'Oreal SE
• Lonza Group Ltd.
• Medline Industries, Inc.
• Medtronic PLC
• Mineral Mine
• Molnlycke Health Care AB
• Nardo's Natural, Inc.
• Natures Formulae Ltd.
• Nature's Bounty Company
• Nestle SA
• Nichiban Co., Ltd.
• Onoxa LLC
• Paul Hartmann AG
• PepsiCo, Inc.
• Pfizer, Inc.
• Piramal Enterprises Ltd.
• Reckitt Benckiser LLC
• Sanofi S.A.
• Smith & Nephew PLC
• Sun Pharmaceuticals Ltd.

LIST OF FIGURES

• FIGURE 1. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET RESEARCH PROCESS
• FIGURE 2. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET DYNAMICS
• TABLE 7. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ORAL CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SKIN CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY WOUND CARE MANAGEMENT PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY INDEPENDENT PHARMACIES & RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 26. CANADA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 38. CHINA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 40. INDIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 75. ITALY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 83. POLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 85. QATAR OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 105. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

The Over-The-Counter Consumer Health Products Market was valued at USD 641.02 billion in 2023, expected to reach USD 679.60 billion in 2024, and is projected to grow at a CAGR of 6.34%, to USD 985.97 billion by 2030.

The scope and definition of over-the-counter (OTC) consumer health products encompass a wide range of health and wellness items available without a prescription, including pain relievers, cold and flu medications, vitamins, supplements, skincare products, and more. These products offer convenience and accessibility to consumers seeking immediate relief or preventive measures, reflecting a growing consumer trend towards self-care and wellness. The necessity for OTC products is driven by increasing health awareness, a rising aging population, and a preference for cost-effective healthcare solutions. They are applied across various end-use segments such as personal health, home healthcare, and elderly care. Market insights indicate that the growth of OTC consumer health products is influenced by factors such as technological advancements in product formulation, increased consumer demand for natural and organic products, and expanding e-commerce platforms enabling easier access. Opportunities lie in personalized healthcare products, leveraging digital health technologies for product enhancement, and untapped markets in emerging economies. However, market growth is challenged by stringent regulatory environments, potential side effects of products, and high competitive pressure with numerous market players. The best areas of innovation include the development of integrated digital solutions for personal health monitoring, research into plant-based and herbal formulations, and sustainable packaging to attract environmentally conscious consumers. The nature of the OTC market is dynamic and highly competitive, necessitating continuous innovation and adaptation to changing consumer preferences and regulatory landscapes. Companies are recommended to invest in market research to understand evolving consumer needs, enhance product formulations through advanced technology, and build strong online platforms to capture the digital-savvy customer. Strengthening distribution networks in emerging markets and developing products tailored to local consumer preferences can also yield significant growth potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Over-The-Counter Consumer Health Products Market

The Over-The-Counter Consumer Health Products Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing popularity of over the counter consumer health products
  • Increasing preference towards natural medicinal products and supplements
  • Surge in disposable income and rise in the spending on non-essential products by consumers
• Market Restraints
  • High cost of development of OTC products
• Market Opportunities
  • Ongoing research and development in the development of over-the-counter consumer health products
  • Growing use of mobile apps and telehealth services to complement OTC product offerings
• Market Challenges
  • Potential risk of misuse and adverse reactions to OTC products

Porter's Five Forces: A Strategic Tool for Navigating the Over-The-Counter Consumer Health Products Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Over-The-Counter Consumer Health Products Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Over-The-Counter Consumer Health Products Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Over-The-Counter Consumer Health Products Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Over-The-Counter Consumer Health Products Market

A detailed market share analysis in the Over-The-Counter Consumer Health Products Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Over-The-Counter Consumer Health Products Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Over-The-Counter Consumer Health Products Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Over-The-Counter Consumer Health Products Market

A strategic analysis of the Over-The-Counter Consumer Health Products Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Over-The-Counter Consumer Health Products Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Amorepacific, Inc., Amway Corporation, Archer Daniels Midland Company, B. Braun SE, Bayer AG, Beiersdorf AG, Boehringer Ingelheim GmbH, Cardiff Sports Nutrition Ltd., Cardinal Health, Inc., Cipla Limited, Cliff Bar & Company, Cosmetic Skin Solutions, LLC, Dr. Reddy's Laboratories, DuPont de Nemours, Inc., Essity AB, Estee Lauder Companies Inc., FastFill Pack, Inc., GKCO Holdings, Inc., Glanbia PLC, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., InSpec Solutions, LLC, Integra Lifesciences Corporation, Johnson & Johnson services, Inc., Koninklijke DSM N.V., L'Oreal SE, Lonza Group Ltd., Medline Industries, Inc., Medtronic PLC, Mineral Mine, Molnlycke Health Care AB, Nardo's Natural, Inc., Natures Formulae Ltd., Nature's Bounty Company, Nestle SA, Nichiban Co., Ltd., Onoxa LLC, Paul Hartmann AG, PepsiCo, Inc., Pfizer, Inc., Piramal Enterprises Ltd., Reckitt Benckiser LLC, Sanofi S.A., Smith & Nephew PLC, and Sun Pharmaceuticals Ltd..

Market Segmentation & Coverage

This research report categorizes the Over-The-Counter Consumer Health Products Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Products, market is studied across Gastrointestinal Products, Nutritional Supplements, Oral Care Products, Skin Care Products, and Wound Care Management Products.
• Based on Distribution Channel, market is studied across Hospital Pharmacy, Hypermarkets & Supermarkets, Independent Pharmacies & Retail Stores, and Online Sales.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing popularity of over the counter consumer health products
    • 5.1.1.2. Increasing preference towards natural medicinal products and supplements
    • 5.1.1.3. Surge in disposable income and rise in the spending on non-essential products by consumers
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development of OTC products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development in the development of over-the-counter consumer health products
    • 5.1.3.2. Growing use of mobile apps and telehealth services to complement OTC product offerings
  • 5.1.4. Challenges
    • 5.1.4.1. Potential risk of misuse and adverse reactions to OTC products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Products: Growing demand for nutritional supplements driven by the health-conscious consumer
  • 5.2.2. Distribution Channel: Increasing preference for online sales channels due to easy accessibility and wide product availability
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Over-The-Counter Consumer Health Products Market, by Products

• 6.1. Introduction
• 6.2. Gastrointestinal Products
• 6.3. Nutritional Supplements
• 6.4. Oral Care Products
• 6.5. Skin Care Products
• 6.6. Wound Care Management Products

7. Over-The-Counter Consumer Health Products Market, by Distribution Channel

• 7.1. Introduction
• 7.2. Hospital Pharmacy
• 7.3. Hypermarkets & Supermarkets
• 7.4. Independent Pharmacies & Retail Stores
• 7.5. Online Sales

8. Americas Over-The-Counter Consumer Health Products Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Over-The-Counter Consumer Health Products Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Over-The-Counter Consumer Health Products Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
  • 11.3.2. iNova to buy Mundipharma's consumer healthcare brands for USD 540 million
  • 11.3.3. WellSpring Consumer Healthcare Acquires OTC Skin Care Brands from Bayer
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Amorepacific, Inc.
• 4. Amway Corporation
• 5. Archer Daniels Midland Company
• 6. B. Braun SE
• 7. Bayer AG
• 8. Beiersdorf AG
• 9. Boehringer Ingelheim GmbH
• 10. Cardiff Sports Nutrition Ltd.
• 11. Cardinal Health, Inc.
• 12. Cipla Limited
• 13. Cliff Bar & Company
• 14. Cosmetic Skin Solutions, LLC
• 15. Dr. Reddy's Laboratories
• 16. DuPont de Nemours, Inc.
• 17. Essity AB
• 18. Estee Lauder Companies Inc.
• 19. FastFill Pack, Inc.
• 20. GKCO Holdings, Inc.
• 21. Glanbia PLC
• 22. GlaxoSmithKline PLC
• 23. Glenmark Pharmaceuticals Ltd.
• 24. InSpec Solutions, LLC
• 25. Integra Lifesciences Corporation
• 26. Johnson & Johnson services, Inc.
• 27. Koninklijke DSM N.V.
• 28. L'Oreal SE
• 29. Lonza Group Ltd.
• 30. Medline Industries, Inc.
• 31. Medtronic PLC
• 32. Mineral Mine
• 33. Molnlycke Health Care AB
• 34. Nardo's Natural, Inc.
• 35. Natures Formulae Ltd.
• 36. Nature's Bounty Company
• 37. Nestle SA
• 38. Nichiban Co., Ltd.
• 39. Onoxa LLC
• 40. Paul Hartmann AG
• 41. PepsiCo, Inc.
• 42. Pfizer, Inc.
• 43. Piramal Enterprises Ltd.
• 44. Reckitt Benckiser LLC
• 45. Sanofi S.A.
• 46. Smith & Nephew PLC
• 47. Sun Pharmaceuticals Ltd.